[Sana Fathima K S]

No. Direct-to-consumer kits are generally less comprehensive and not intended for medical diagnosis. Clinical genetic testing, ordered and interpreted by a geneticist, is more targeted, more rigorously validated, and appropriate for medical decision-making.

[Sana Fathima K S]

Yes, predictive testing is available for certain late-onset neurological conditions. Because these results carry significant emotional and life-planning implications, genetic counseling before and after testing is strongly recommended.

[Sana Fathima K S]

Yes. Since family history isn’t available, genetic testing can be especially useful for adopted children to identify or rule out inherited conditions and guide their medical care.

[Sana Fathima K S]

Generally, testing for conditions that only appear in adulthood, such as certain hereditary cancers, is deferred until the child is old enough to understand and decide for themselves, unless early knowledge would change medical care in childhood. This is an important discussion to have with a genetic counselor.

[Sana Fathima K S]

Yes, genetic information is treated as confidential medical data. It is shared only with you and the healthcare providers directly involved in your care, and is not disclosed to third parties without your consent.

[Sana Fathima K S]

*Biopsy and mosaicism: The trophectoderm biopsy samples only a few cells, which may not always represent the full embryo, particularly in mosaic embryos.
*No embryos may qualify for transfer: In women with diminished ovarian reserve or advanced maternal age, it is possible that no embryo is classified as euploid in a given cycle.
*Additional cost and time: The biopsy, genetic analysis, and typically an accompanying frozen embryo transfer add to the overall cost and duration of treatment.
*Does not test for all genetic conditions: Preimplantation Genetic Testing for Aneuploidy screens for chromosome number abnormalities only; it does not detect single-gene disorders (which require *Preimplantation Genetic Testing for Monogenic disorders) or structural rearrangements below its resolution threshold.
*Not a guarantee of pregnancy: A euploid result improves the odds but does not guarantee implantation or a live birth, as uterine, endocrine, and other factors also influence outcomes.

[Sana Fathima K S]

Yes, with an important clarification on what “success” means. In women over 37 years, the proportion of chromosomally abnormal embryos rises steeply, often exceeding 60–70% of blastocysts formed. For this age group, current evidence shows Preimplantation Genetic Testing for Aneuploidy:

*Improves success per embryo transfer: Transferring a chromosomally normal (euploid) embryo yields significantly higher implantation and live birth rates per transfer compared to an untested embryo of similar grade, since the largest single cause of failure in this age group has been screened out.
*Reduces miscarriage rates: Since a majority of miscarriages in this age group are chromosomal in origin, transferring euploid embryos meaningfully lowers pregnancy loss rates.
*Shortens time to a successful pregnancy: By avoiding transfers of embryos destined to fail or miscarry, couples often reach a live birth in fewer transfer attempts.
*Does not increase the cumulative live birth rate per egg retrieval cycle: Preimplantation Genetic Testing for Aneuploidy does not create more euploid embryos, it identifies which existing embryos are euploid. If a woman over 37 years produces very few or no euploid embryos in a cycle, testing does not change that underlying biological reality.
for women over 37 years, Preimplantation Genetic Testing for Aneuploidy is most valuable for improving the efficiency and predictability of each transfer, not for increasing the total number of embryos available.

[Sana Fathima K S]

*Women of advanced maternal age (typically 35 years and above)
*Couples with recurrent pregnancy loss
*Couples with a history of repeated In Vitro Fertilization implantation failure
*Couples where one partner carries a balanced chromosomal translocation or structural rearrangement
*Couples who wish to transfer a single embryo (elective single embryo transfer) while maintaining reasonable success rates
Consultation with a geneticist or genetic counselor will be helpful to see if PGT-A is necessary.

[Sana Fathima K S]

Chromosomal aneuploidy is the leading cause of implantation failure and first-trimester miscarriage, and its incidence rises sharply with maternal age. By identifying which embryos are chromosomally normal before transfer, Preimplantation Genetic Testing for Aneuploidy allows clinicians to prioritize the embryo(s) with the highest biological likelihood of implanting and progressing to a healthy pregnancy, rather than selecting based on morphology (appearance) alone.

[Sana Fathima K S]

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a laboratory technique used alongside In Vitro Fertilization (IVF) to screen embryos for an abnormal number of chromosomes before they are transferred to the uterus. A small number of cells are biopsied from the trophectoderm (the outer layer of a day 5–6 blastocyst, a cluster of dividing cells that forms five to six days after a sperm fertilizes an egg) and analyzed using next-generation sequencing. Embryos are then classified as chromosomally normal (euploid), abnormal (aneuploid), or mosaic (a mix of normal and abnormal cell lines).

[Sana Fathima K S]

Screening tests estimate risk and tell you whether further testing may be needed; they don’t give a final answer. Diagnostic tests confirm or rule out a condition with much higher certainty. For example, in pregnancy, a screening test might flag increased risk, and a diagnostic test would then confirm whether the baby is actually affected.

[Sana Fathima K S]

A single-gene test looks at one specific gene, usually when a particular condition is strongly suspected. A gene panel tests multiple related genes at once, which is useful when a group of conditions share similar symptoms and the exact cause isn’t clear yet.

[Sana Fathima K S]

These are conditions influenced by multiple genes working together, along with lifestyle and environmental factors, rather than a single gene change. Common examples include diabetes, hypertension, and many heart conditions. Genetic testing for these conditions typically estimates risk rather than giving a yes/no answer.

[Sana Fathima K S]

Mosaicism happens when a person has two or more genetically different sets of cells in their body, usually due to a gene change occurring after conception rather than being present from the start. This can sometimes make a condition milder or affect only certain body parts, and it can occasionally make test results more complex to interpret.

[Sana Fathima K S]

These are conditions caused by changes in mitochondrial DNA, which is inherited only from the mother, unlike most other genes. They often affect organs with high energy needs, such as the brain, muscles, and heart, and require specialized testing.

[Author]

Posts